NIAID's HIV/AIDS Research Program

Although progress has been made in the global fight against HIV/AIDS, the epidemic continues to devastate the United States and the international community with 56,300 new HIV infections each year in the U.S. and an estimated 33 million people living with HIV worldwide. As the leading U.S. government institute for HIV/AIDS research, NIAID is committed to conducting the research necessary to successfully end the fight against HIV/AIDS.

Through laboratories and clinics on the NIH campus in Bethesda, Md., and a vast network of supported research at universities, medical centers and clinical trial sites around the globe, NIAID is working to better understand HIV and how it causes disease, find new tools to prevent HIV infection including a preventive vaccine, develop new and more effective treatments for people infected with HIV, and hopefully, find a cure.

Discovering the Basics of HIV/AIDS

Because of its complex nature, HIV is an extremely tough infectious disease for researchers to combat. A better understanding of the basic biology and relationship between HIV/AIDS and the human immune system is the key to the discovery of new and improved medicines for people infected with HIV and methods for preventing HIV infection, including a vaccine. Through its on-campus laboratories and grant-funded extramural research, NIAID is continuing to explore how HIV infects individual cells and causes disease to unlock new targets to stop the virus and opportunities to enhance the immune system response to infection.

You can leave a response, or trackback from your own site.

    Ads

    Free Domain

    CO.CC:Free Domain - www.Co.cc